Selection of blockbuster announcements
1、$AVIC (02357.HK) $Subsidiary AVIC Electronics implements the introduction of new shares to absorb and merge AVIC machinery and electronics.
CNAC Science and Technology Industry announced that AVIC, a subsidiary of AVIC, absorbed and merged AVIC through the issuance of A shares, with a proportion of 0.6605 AVIC shares for every one AVIC share, which is expected to involve the issuance of 2.565 billion A shares. Upon completion, AVIC Machinery and Machinery will apply for delisting and cancellation from the Shenzhen Stock Exchange.
AVIC also plans to issue AVIC A shares to no more than 35 specific investors (including AVIC, Aviation Investment, AVIC Shenfei and Aviation Industry Chengfei) to raise no more than 5 billion yuan. AVIC has signed subscription agreements with AVIC, Aviation Investment, AVIC Shenfei and Aviation Industry Chengfei, with the above four companies subscribing for 500m, 300m, 180 million and 180 million yuan respectively.
2、$minimally invasive robot-B (02252.HK) $(02252): the self-developed Tumai ®endoscopic surgery robot completes the first 5G remote surgery.
The minimally invasive robot announced that the group's independently developed Tumai ®endoscopic surgery robot successfully completed the world's furthest 5G ultra-remote robot surgery through the 5G connection between Jiangsu Provincial people's Hospital and Xinjiang Kezhou people's Hospital.
3、$Yasheng Pharmaceutical-B (06855.HK) $Release of positive clinical data of Bcl-2 inhibitor APG-2575 in the treatment of Chinese patients with recurrent / refractory non-Hodgkin's lymphoma
Yasheng Pharmaceutical-B (06855) announced that at the 2022 Annual meeting of the European Hematological Association (EHA 2022), the company presented phase I clinical trial data on the development of a new class 1 drug, Bcl-2 selective inhibitor APG-2575, in the treatment of Chinese patients with relapsed / refractory non-Hodgkin's lymphoma (r NHLs).
4、$BeiGene, Ltd. (06160.HK) $The State Drug Administration approved Baze'an ®combined with chemotherapy for first-line treatment of patients with recurrent or metastatic nasopharyngeal carcinoma.
China's State Drug Administration (NMPA) has approved BeiGene, Ltd. 's anti-PD-1 antibody drug ®(tirelizumab injection) combined with chemotherapy for first-line treatment of patients with recurrent or metastatic nasopharyngeal carcinoma (NPC), BeiGene, Ltd. announced.
5、$Great Wall Motor (02333.HK) $On June 10, 13.074 million shares were repurchased at a cost of HK $199 million
Great Wall Motor announced that on June 10, 2022, he would spend HK $199 million to buy back 13.074 million shares at a repurchase price of HK $14.18-HK $15.50 per share.
6、$PICC Property and Casualty (02328.HK) $The original insurance premium income in the first five months was about 222.786 billion yuan, an increase of 10% over the same period last year.
PICC Property and Casualty announced that from January to May this year, the original insurance premium income reached 222.786 billion yuan (the same below), an annual increase of 10%. Of this total, motor vehicle insurance totaled 104.747 billion yuan, up 6.2 percent year-on-year, while accidental injury and health insurance increased by 16.9 percent to 61.11 billion yuan.
Important matters
Ping An Insurance (02318) adjusted the price ceiling of buyback A shares to no more than 80.20 yuan per share in a centralized bidding transaction.
BeiGene, Ltd. (06160): the State Drug Administration approved Bai Zean ®combined with chemotherapy for first-line treatment of patients with recurrent or metastatic nasopharyngeal carcinoma
Yasheng Medicine-B (06855) publishes positive clinical data of Bcl-2 inhibitor APG-2575 in the treatment of Chinese patients with recurrent / refractory non-Hodgkin's lymphoma
Minimally invasive Robot-Tumai ®Endoscopic surgery Robot independently developed by B (02252) completes the first 5G remote surgery
Federal Pharmaceutical (03933): evaluation of consistency of quality and efficacy of piperacillin sodium and tazobactam sodium for injection
Chinese Mobile Games (00302) launched a copyright distribution platform for digital works of art with fish.
AVIC Science and Engineering (02357): AVIC Electronics plans to absorb and merge AVIC Mechatronics to realize the professional integration of avionics and mechatronics systems.
Bank of China Leasing (01606) enters into a financial lease contract with Jinzhou Port shares
Lu Jin (01098) intends to sell 45% stake in Hebei Jiantou Lujin.
China Communications Construction (01800): plan to increase capital in the construction of Yancheng
Touyun Bio (01332) obtained Food production license of Chlamydomonas Rheinis and related products
Wuxi Apptec (02359): actual controllers and consistent actors plan to reduce a total of no more than 88.6803 million A-shares
Financial data
China Natural Gas (00931) issued a profit warning with an expected annual consolidated loss of HK $170 million to HK $200 million.
Zhongji Longevity Science (00767) released its 2021 results, with a profit attributable to shareholders of HK $6.055 million, turning losses into profits compared with the same period last year.
Hongan Real Estate (01243) issued a profit warning and expected annual profit attributable to shareholders to decrease by no more than 45% compared with the same period last year.
Piyuantang (00897) expects the annual loss attributable to the owner to be no more than HK $140 million.
Operation data
Contract sales of Greenland in Hong Kong (00337) in the first five months are about 5.818 billion yuan.
Longguang Group (03380) has contract sales of 26.6 billion yuan in the first five months.
The total contract sales of Silver City International Holdings (01902) in the first five months is about 5.11 billion yuan.
Dragonair China Real Estate (06968) May contract sales of about 637.8 million yuan
China Pacific Insurance (02601): the original insurance business income of Pacific Life Insurance in the first five months was 127.346 billion yuan, an increase of 5.1% over the same period last year.
PICC Property and Casualty's original insurance premium income in the first five months of 02328 was about 222.786 billion yuan, an increase of 10% over the same period last year.
Hong Kong Science and Technology Exploration (01137): total merchandise transaction volume of HKTVmall5 monthly order is HK $613 million, up 19.3% from the same period last year.
Repurchase cancellation
HSBC Holdings PLC (00005) bought back a total of 3.184 million shares on the stock exchanges of the United Kingdom and Hong Kong on June 10.
AIA Group Limited (01299) HK $160 million buyback 2 million shares on June 10th
Great Wall Motor (02333) buys back 13.074 million shares on June 10th
Byd Company Limited (01211) buys back 384300 shares on June 10th
Genting Xinyao-B (01952) cancels 1.6155 million repurchased shares on June 10
Harmonious Automobile (03836) buyback 44000 shares on June 10th
China Conch Venture (00586) spent 3.8206 million Hong Kong dollars to buy back 216000 shares on June 10.
Yongsheng New Materials (03608) write off 24.535 million shares on June 10
Saisheng Pharmaceutical (06600) buys back 120000 shares on June 10th
Additional rights issue
China carbon Neutralization (01372) intends to issue 10 million additional subscription shares at a premium of about 1.64%, or raise a net HK $30 million.
China National Building Material (03323) gets controlling shareholder to increase 42.18 million H shares
China Ocean Development (08047) proposes to allocate 800 million shares at a discount of about 11.5%, with a net raise of about HK $79.9 million.
Haichang Ocean Park (02255) completed the placement of 57.001 million shares, net raising about HK $309.8 million
Stock option
Wuxi Biologics (02269) granted a total of 6.9844 million restricted shares
JD Logistics, Inc. (02618) issues 700000 shares under the share Award Scheme
XIAOMI Group-W (01810) issued about 1.6183 million shares due to the exercise of the option.
Shengye (06069) granted 1.34 million restricted shares and 11 million share options
MGM China (02282) granted a total of 28.6144 million share options
Dividend dividend
China Molybdenum's (03993) H shares will pay a final dividend on July 27th
Hypree (09989) will pay a final dividend of HK $0.41 per 10 shares on August 15th.
Jiaxing Gas (09908) plans to pay a final dividend of RMB0.15 per share (including tax) in 2021 on July 5.
Shanxi Merchants Bank (02558) plans to pay a final dividend of 10 yuan per 100 shares (including tax) on July 29th.
Suffolou Group (01978) plans to pay a final dividend of HK6.05 cents per share on June 30th.
Ping An Insurance (02318) A shares will pay a cash dividend of 1.50 yuan per share on June 20.
Tianjin Entrepreneurship Environmental Protection Co., Ltd (01065) A shares will pay a cash dividend of 0.146 yuan per share on June 17.
Xingyi Water (02281) proposes to pay a final dividend of RMB0.050 per share (including tax).
Bond bill
Territorial Holdings (06999) made an exchange offer for outstanding 12.0% preferred bills due in 2022.
China Rallway (00390) 2022 corporate bond (second issue) has a coupon of 2.9%.
China Rallway (00390): 21 China Railway Y3 and 21 China Railway Y4 will pay interest on June 20
China National Building Material (03323) intends to reduce the coupon rate of "17 building materials 02" for 2 years after its existence.
Edit / irisz